Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach
暂无分享,去创建一个
G. Thiene | C. Basso | A. Ludolph | U. Sechtem | A. Sperfeld | A. Yilmaz | H. Mahrholdt | H. Gdynia | G. Meinhardt | H. Baccouche
[1] S. Mavrogeni,et al. Myocarditis in a patient with Duchenne muscular dystrophy detected by cardiovascular magnetic resonance and cardiac biopsy. , 2009, International journal of cardiology.
[2] M. Cheitlin. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2009 .
[3] G. Sutherland,et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[4] E. McNally. Duchenne muscular dystrophy: how bad is the heart? , 2008, Heart.
[5] E. Niggli,et al. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. , 2008, Cardiovascular research.
[6] K. Klingel,et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2008, Heart.
[7] A. Maisel,et al. State-of-the-Art PaperNatriuretic Peptides , 2007 .
[8] J. Towbin,et al. Myocardial infarction, viral infection, and the cytoskeleton final common pathways of a common disease? , 2007, Journal of the American College of Cardiology.
[9] A. Kerr,et al. B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation , 2007, Heart.
[10] J. Dyck,et al. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.
[11] C. Rochitte,et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. , 2007, Journal of the American College of Cardiology.
[12] Petros Syrris,et al. Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.
[13] N. Dalton,et al. Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy , 2006, Circulation.
[14] Vincenzo Giglio,et al. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. , 2007, The American journal of cardiology.
[15] K. Klingel,et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.
[16] M. Jessup,et al. Stage B Heart Failure: Management of Asymptomatic Left Ventricular Systolic Dysfunction , 2006, Circulation.
[17] R. Ohye,et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Jefferies J, Eidem B, Belmont J, Craigen W, Ware S, Fernbach S, Neish S, Smith E, Towbin J (2005) Circulation 112: 2799-2804: Commentary , 2005 .
[18] J. Belmont,et al. Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy , 2005, Circulation.
[19] S. Caruthers,et al. Occult Cardiac Contractile Dysfunction in Dystrophin-Deficient Children Revealed by Cardiac Magnetic Resonance Strain Imaging , 2005, Circulation.
[20] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[21] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[22] H. Bécane,et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. , 2005, Journal of the American College of Cardiology.
[23] D. Pennell,et al. Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy , 2004, Heart.
[24] Udo Sechtem,et al. Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.
[25] C. Badorff,et al. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside , 2004, Medical Microbiology and Immunology.
[26] A. Kerr,et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. , 2003, Journal of the American College of Cardiology.
[27] Pedro Lozano. Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.
[28] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[29] C. Badorff,et al. Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy , 2000, Circulation research.
[30] Neil E. Bowles,et al. The “Final Common Pathway” Hypothesis and Inherited Cardiovascular Disease The Role of Cytoskeletal Proteins in Dilated Cardiomyopathy , 2000, Herz.
[31] M. Martone,et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.
[32] L. Kunkel,et al. Dystrophies and heart disease. , 1997, Current opinion in cardiology.
[33] G. Danieli,et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.
[34] L. Politano,et al. Evaluation of the cardiomyopathy in becker muscular dystrophy , 1995, Muscle & nerve.
[35] M. Thambyayah,et al. Prevalence and incidence of Becker muscular dystrophy , 1991, The Lancet.
[36] N. Reichek,et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[37] E. Henze,et al. Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. , 1984, Circulation.
[38] S. Pitner,et al. An Ultrastructural Basis for Electrocardiographic Alterations Associated with Duchenne's Progressive Muscular Dystrophy , 1978, Circulation.
[39] K. Frankel,et al. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. , 1976, Human pathology.
[40] W. Roberts,et al. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. , 1967, The American journal of medicine.